Simris Group Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Alexis McIntosh

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	less than a year
Proprietà del CEO	n/a
Durata media del management	1.3yrs
Durata media del Consiglio di amministrazione	3.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

Is Simris Alg (STO:SIMRIS B) A Risky Investment?

Dec 22

AMMINISTRATORE DELEGATO

Alexis McIntosh

less than a year

Mandato

Dr. Alexis Roberts McIntosh is Chief Executive Officer of Simris Group AB (PUBL) from March 2024. She holds a Ph D in Medicinal Chemistry.She began her career with GlaxoSmithKline and has since spent the...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Christoffer Tell	Chief Financial Officer	3.7yrs	SEK 1.08m	0.23% SEK 62.9k
Alexis McIntosh	Chief Executive Officer	less than a year	Nessun dato	Nessun dato
Heike Enke	Chief Science Officer for Non-ADC Technologies of Simris Biologics	1.3yrs	Nessun dato	Nessun dato

1.3yrs

Durata media

Gestione esperta: Il team dirigenziale di SIMRIS B non è considerato esperto (durata media 1.3 anni), il che suggerisce un nuovo team.

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Lars Magnus Hogstrom	Independent Director	4.9yrs	SEK 70.00k	0.72% SEK 196.5k
Jonathan Royce	Chairman of the Board	less than a year	Nessun dato	Nessun dato
Frank Puccio	Independent Director	3.5yrs	SEK 70.00k	1.86% SEK 507.5k

3.5yrs

Durata media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di SIMRIS B sono considerati esperti (durata media dell'incarico 3.5 anni).

Simris Group Gestione

Gestione criteri di controllo 1/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Simris Group Announces Board Changes

Simris Group AB (Publ) Appoints Jonathan Royce as Members of the Board

Insufficient new directors

Simris Group AB (publ) Announces Robert Quandt Declines Re-Election as Member of Board

Simris Group AB (PUBL), Annual General Meeting, Jun 28, 2024

Simris Group AB (PUBL) Announces CEO Changes

Recent updates

Third quarter 2024 earnings released

Simris Group Announces Board Changes

New major risk - Share price stability

Second quarter 2024 earnings released

Simris Group AB (Publ) Appoints Jonathan Royce as Members of the Board

Insufficient new directors

Simris Group AB (publ) Announces Robert Quandt Declines Re-Election as Member of Board

Simris Group AB (PUBL) to Report Q3, 2024 Results on Nov 13, 2024

Simris Group AB (PUBL), Annual General Meeting, Jun 28, 2024

Simris Group AB (PUBL) Announces CEO Changes

Full year 2023 earnings released: kr0.11 loss per share (vs kr0.17 loss in FY 2022)

Third quarter 2023 earnings released

Simris Group AB (PUBL) announced that it has received SEK 2.9295 million in funding

Independent Chairman recently bought kr6.4m worth of stock

New major risk - Shareholder dilution

Independent Chairman recently bought kr55k worth of stock

Simris Group AB Confirms New Patent Application from Its Adc-Payload Platform

Second quarter 2023 earnings released

Simris Alg AB (publ) to Report Q3, 2023 Results on Nov 08, 2023

Full year 2022 earnings released: kr0.17 loss per share (vs kr0.36 loss in FY 2021)

Full year 2022 earnings released: kr0.14 loss per share (vs kr0.36 loss in FY 2021)

Is Simris Alg (STO:SIMRIS B) A Risky Investment?

Second quarter 2022 earnings released: kr0.039 loss per share (vs kr0.092 loss in 2Q 2021)

Simris Alg AB (publ) (OM:SIMRIS B) entered into a binding Letter Of Intent to acquire 100% of the shares in Cyano Biotech GmbH.

Interim Executive Chairman recently bought kr1.0m worth of stock

First quarter 2022 earnings released: kr0.051 loss per share (vs kr0.087 loss in 1Q 2021)

No independent directors

First quarter 2022 earnings released

Simris Alg AB (Publ) Appoints Julian Read as Chief Executive Officer, Effective on May 16, 2022

Simris Alg AB (publ), Annual General Meeting, May 25, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released

Interim Executive Chairman recently bought kr149k worth of stock

Chief Executive Officer Fredrika Gullfot has left the company

Second quarter 2021 earnings released

Full year 2020 earnings released: kr0.60 loss per share (vs kr2.29 loss in FY 2019)

New 90-day low: kr0.78

New 90-day low: kr0.80

New 90-day low - kr0.96

Earnings released

Simris Alg AB (publ) to Report Q2, 2020 Results on Aug 18, 2020

New 90-day high - kr2.67

Simris Alg AB (publ) has completed a Composite Units Offering in the amount of SEK 29.074529 million.

AMMINISTRATORE DELEGATO

Mandato

Gruppo dirigente

Durata media

Membri del Consiglio di amministrazione

Durata media